Gardiner Healthcare Acquisitions Corp.
GDNR
NASDAQ Global Market10.90
USD
+0.07
- -
CIK
0001858912
ISIN
US3655061048
CUSIP
365506104
Return %
Stock
S&P500
1Y
4.91
18.21
3Y
11.00
63.29
5Y
11.00
74.90
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Marc F. Pelletier
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 3107 Warrington Road Shaker Heights OH United States of America 44120
- IPO Date
- Jan 13, 2022
- CIK
- 0001858912
- Similar Companies
- Business
- Gardiner Healthcare Acquisitions Corp. Gardiner Healthcare Acquisitions Corp. (Nasdaq: GDNR) constitutes a blank check company, or special purpose acquisition company (SPAC), focused on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare or healthcare-related industries, primarily targeting high-growth entities in North American or European life sciences and medical technology sectors, including small and large molecule therapeutics; the company conducts no significant independent operations or revenue generation pending such a transaction. Gardiner Healthcare Acquisitions Corp. maintains its headquarters in Shaker Heights, Ohio, where it was incorporated in 2021 under the sponsorship of Gardiner Healthcare Holdings, LLC, Chardan Gardiner LLC, and CCMAUS Pty Ltd. The firm offered 7.5 million units at $10 each in its December 2021 initial public offering, raising $75 million (upsized to $86.25 million), with units comprising one Class A common share and one warrant exercisable at $11.50 per share. In a major development, Gardiner Healthcare Acquisitions Corp. announced in December 2023 its decision by the board of directors to dissolve and liquidate without consummating an initial business combination, redeeming all public shares effective December 18, 2023, at a pro rata portion of trust account proceeds (net of dissolution expenses), delisting from Nasdaq via Form 25, and terminating SEC registration via Form 15; public shares ceased trading prior to redemption, while warrants carried no redemption rights, and sponsor-held shares waived liquidating distributions. Despite this liquidation, certain platforms continue to reference Gardiner Healthcare Acquisitions Corp. in 2025 contexts, including stock pricing data as of late 2025, though the entity operates in wind-down mode with no active pursuit of healthcare targets or new offerings.
Gardiner Healthcare Acquisitions Corp. Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination
Gardiner Healthcare Acquisitions Corp. Receives Notice Regarding Late Form 10-Q Filing From The Nasdaq Stock Market LLC
Gardiner Healthcare Acquisitions Corp. Announces Intent to Extend